Annabella

High-Level Overview

Annabella is a femtech company specializing in innovative breast pumps that mimic a baby's natural suckling motion using tongue-simulation technology, delivering up to 50% more milk expression efficiency and greater comfort compared to leading brands.[2][3][4] Founded in 2016 and based in West Palm Beach, Florida, it serves breastfeeding mothers worldwide, solving pain points in traditional pumping like discomfort and low yield through FDA-cleared, patented devices including single and double electric pumps, plus accessories.[1][2][4] The company has raised over $10.35M in funding, including an $8.5M seed round in 2024 supporting U.S. expansion, and reported 154% revenue growth to NIS 4.5M in H1 2025 from European, Israeli, and U.S. online sales.[1][2][4]

Annabella has captured 5-10% monthly market share in Israel since its 2023 launch there, sold over 4,000 units via retail, and holds 8 patents in breastfeeding tech while earning innovation awards.[1][3][4]

Origin Story

Annabella was founded in 2016 by Masha Waldberg (Founder & VP), Senia Waldberg (Founder & CMO), and Uri Yaffe (Founder & CEO), driven by a mission to empower mothers with superior femtech products that prioritize comfort and efficiency in breastfeeding.[3][4] The core idea emerged from addressing gaps in existing breast pumps, leading to patented technology that simulates a baby's tongue motion for a more natural experience.[2][5] Early traction built in Israel with a February 2023 retail launch via Shilav stores, achieving rapid 5-10% monthly market penetration and over 4,000 units sold, plus a Shark Tank feature.[3][4] Pivotal moments include FDA clearance, first patents in the US and China, Israel's fastest crowdfunding at $3M, and a major $8.5M seed round in 2024 fueling U.S. market entry.[1][2][4]

Core Differentiators

• Tongue-Simulation Technology: Patented mechanism mimics a baby's natural suckling, pumping up to twice as much milk as competitors while feeling more like breastfeeding; clinical studies show 50% more milk output.[2][3][5]
• FDA-Cleared Efficiency and Comfort: Adjustable breast shield in single/double pumps enhances user experience; recent 2024 double pump launch boosts speed for busy mothers.[1][2][4]
• Proven Market Performance: 154% H1 2025 revenue growth, rapid Israeli dominance (5-10% monthly share), and U.S. expansion via online sales and distributors.[1][3]
• Innovation Portfolio: 8 patents in breastfeeding/infant feeding, plus awards; positioned as a Challenger in connected breastfeeding pumps & wearables alongside Willow and Medela.[2]

Role in the Broader Tech Landscape

Annabella rides the booming femtech wave, targeting the $50B+ maternal health market with smart, app-integrated breastfeeding devices amid rising demand for portable, data-tracking wearables.[2] Timing aligns with post-pandemic focus on women's health tech, remote work enabling U.S./Europe expansion, and regulatory wins like FDA clearance accelerating adoption.[1][4] Favorable forces include aging millennial motherhood, e-commerce growth in baby products, and investor enthusiasm—evidenced by $10M+ funding and crowdfunding success—positioning Annabella to disrupt incumbents like Medela.[2][4] It influences the ecosystem by advancing connected pumps with real-time tracking and personalization, fostering innovation in babycare wearables.[2]

Quick Take & Future Outlook

Annabella's trajectory points to scaled U.S. dominance, with H1 2025's 154% growth signaling potential for multi-fold revenue in 2026 via expanded double-pump lines and accessories.[1] Trends like AI-personalized femtech, global e-commerce penetration, and wearables integration will propel it, possibly eyeing Series A or acquisitions by medtech giants. Its influence could redefine breastfeeding standards, empowering more mothers—building on early wins to claim a lasting slice of the maternal wellness revolution.[2][4]